Tepotinib-induced interstitial lung disease in a patient with adenosquamous lung carcinoma
{{output}}
We report a case of drug-induced lung injury in an 88-year-old man with non-small cell lung cancer harboring an MET exon 14 skipping mutation. The patient developed dyspnea and new ground-glass opacities shortly after the initiation of tepotinib, an oral MET-t... ...
